TNGX Tango Therapeutics, Inc.: institutional ownership and insider trading
260 funds reported holding $6.76B of Tango Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $940M, with 71 new positions and 22 funds selling out; over the last 12 months insiders bought $0 and sold $7.69M on the open market; over its last four quarters it reported revenue of $53.8M and net income of −$124M.
TNGX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$55.3M, EPS -0.37
- Quarter ended Mar 31, 2026: revenue $0, net income −$45.5M, EPS -0.32
- Quarter ended Dec 31, 2025: revenue $0, net income −$38.8M, EPS -0.29
- Quarter ended Sep 30, 2025: revenue $53.8M, net income $15.9M, EPS 0.13
Famous investors holding TNGX
- Renaissance Technologies (Renaissance Technologies): $23.4M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $15.5M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $7.56M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $10.6M, 0.0% of the portfolio
Largest institutional holders of TNGX
- RTW INVESTMENTS, LP — $435M
- BlackRock, Inc. (BLK) — $389M
- FMR LLC — $386M
- FARALLON CAPITAL MANAGEMENT, L.L.C. — $384M
- Boxer Capital Management, LLC — $340M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $312M
- TCG Crossover Management, LLC — $284M
- Paradigm Biocapital Advisors LP — $199M
- PRICE T ROWE ASSOCIATES INC /MD/ — $198M
- Siren, L.L.C. — $193M
Recent TNGX insider trades
- Oct 1, 2026: Crystal Adam sold 27,000 shares ($661K)
- Sep 22, 2026: Newcomb Jessica sold 8,200 shares ($199K)
- Sep 1, 2026: Crystal Adam sold 27,000 shares ($604K)
- Aug 3, 2026: Crystal Adam sold 27,000 shares ($736K)
5%+ owners
- Farallon Capital Management, L.L.C.: 9.8% (Schedule 13G/A, filed Aug 14, 2026)
- RTW Investments, LP: 9.3% (Schedule 13G, filed May 15, 2026)
- Dapice Joshua J.: 7.8% (Schedule 13G/A, filed May 11, 2026)
- TCG Crossover GP II, LLC: 7.0% (Schedule 13G/A, filed Aug 14, 2026)
- FMR LLC: 6.9% (Schedule 13G, filed May 6, 2026)
- THE GOLDMAN SACHS GROUP, INC.: 6.0% (Schedule 13G, filed Aug 14, 2026)
Who owns the most TNGX stock?
The largest institutional holders of Tango Therapeutics, Inc. in the latest 13F filings are RTW INVESTMENTS, LP ($435M), BlackRock, Inc. (BLK) ($389M), FMR LLC ($386M).
Are insiders buying or selling TNGX?
Over the last 12 months insiders bought $0 and sold $7.69M of Tango Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own TNGX?
Renaissance Technologies, Izzy Englander, Two Sigma, Ken Griffin.
What was TNGX's revenue last quarter?
Tango Therapeutics, Inc. reported revenue of $0 for the quarter ended June 30, 2026, with net income of −$55.3M.
Which ETFs hold TNGX?
32 ETFs and mutual funds hold it among their top 100 positions, including XBI, FBIOX, PRJIX, PRHSX.